Beranda › Penyakit Paru Interstisial › Minnesota
Uji klinis Penyakit Paru Interstisial di Minnesota
14 studi untuk Penyakit Paru Interstisial mencari peserta di lokasi di Minnesota.
Kota di Minnesota
Teks studi resmi (Bahasa Inggris)
FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression
- University of Minnesota, Minneapolis
- Mayo Clinic, Rochester, Rochester
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07540988A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
- University of Minnesota, Minneapolis
Menerima pesertaFase 3
Usia 40 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07201922LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- University of Minnesota, Minneapolis
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05798923Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension
- University of Minnesota, Minneapolis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Sep 2026 · NCT06911632DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Mayo Clinic - Rochester, Rochester
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06388421Platform Clinical Study for Conquering Scleroderma
- Mayo Clinic, Rochester
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Agu 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- Mayo Clinic Rochester, Rochester
Menerima pesertaFase 2/3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06328777Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of Minnesota, Minneapolis
Menerima pesertaStudi observasional
Usia 21 ke atas · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT01915511Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease
- Mayo Clinic, Rochester
Menerima pesertaFase 2
Usia 4 ke atas · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT04925375Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
- University of Minnesota Health Clinical Research Unit (CRU), Minneapolis
- Mayo Clinic, Rochester
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Jul 2026 · NCT05943535TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients
- University of Minnesota, Minneapolis
Menerima pesertaStudi observasional
Hingga usia 24 · Semua jenis kelamin · Diperbarui 22 Jun 2026 · NCT04098445Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
- Mayo Clinic, Rochester
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Apr 2026 · NCT03478826Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease
- University of Minnesota, Minneapolis
- Mayo Clinic in Rochester, Rochester
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mar 2026 · NCT06751069Efficacy of Two Doses of Duloxetine & Amitriptyline in Interstitial Lung Disease-related Cough
- Mayo Clinic in Rochester, Rochester
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 21 Jan 2026 · NCT05120934Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.